High ETV1 levels are correlated with shorter prostate-specific antigen (PSA) recurrence in prostate cancer, while nuclear overexpression of ETV1 is associated with longer overall survival in esophageal adenocarcinoma [47, 48]. Here, ETV1 is linked to esophageal adenocarcinoma.